Difference between revisions of "About-cancer/treatment/drugs/imatinibmesylate"
Jump to navigation
Jump to search
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Imatinib Mesylate == | + | == Imatinib Mesylate == <!--T:1--> |
| + | <!--T:2--> | ||
This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. | ||
| + | <!--T:3--> | ||
'''US Brand Name(s)''' | '''US Brand Name(s)''' | ||
| + | <!--T:4--> | ||
Gleevec | Gleevec | ||
| + | <!--T:5--> | ||
'''FDA Approved''' | '''FDA Approved''' | ||
| + | <!--T:6--> | ||
Yes | Yes | ||
| + | <!--T:7--> | ||
FDA label information for this drug is available at DailyMed. | FDA label information for this drug is available at DailyMed. | ||
| + | <!--T:8--> | ||
'''Use in Cancer''' | '''Use in Cancer''' | ||
| + | <!--T:9--> | ||
Imatinib mesylate is approved to treat: | Imatinib mesylate is approved to treat: | ||
| + | <!--T:10--> | ||
*'''Acute lymphoblastic leukemia''' in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment). In children, it is used as the first treatment after the disease is diagnosed. | *'''Acute lymphoblastic leukemia''' in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment). In children, it is used as the first treatment after the disease is diagnosed. | ||
| + | <!--T:11--> | ||
*'''Chronic eosinophilic leukemia''' or '''hypereosinophilic syndrome.''' | *'''Chronic eosinophilic leukemia''' or '''hypereosinophilic syndrome.''' | ||
| + | <!--T:12--> | ||
*'''Chronic myelogenous leukemia''' that is Philadelphia chromosome positive. | *'''Chronic myelogenous leukemia''' that is Philadelphia chromosome positive. | ||
| + | <!--T:13--> | ||
*'''Dermatofibrosarcoma protuberans.''' | *'''Dermatofibrosarcoma protuberans.''' | ||
| + | <!--T:14--> | ||
*'''Gastrointestinal stromal tumor (GIST).''' | *'''Gastrointestinal stromal tumor (GIST).''' | ||
| + | <!--T:15--> | ||
*'''Myelodysplastic/myeloproliferative neoplasms.''' | *'''Myelodysplastic/myeloproliferative neoplasms.''' | ||
| + | <!--T:16--> | ||
*'''Systemic mastocytosis.''' | *'''Systemic mastocytosis.''' | ||
| + | <!--T:17--> | ||
Imatinib mesylate is also being studied in the treatment of other conditions and types of cancer. | Imatinib mesylate is also being studied in the treatment of other conditions and types of cancer. | ||
| + | <!--T:18--> | ||
'''More About Imatinib Mesylate''' | '''More About Imatinib Mesylate''' | ||
| + | <!--T:19--> | ||
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. | ||
| + | <!--T:20--> | ||
MedlinePlus Information on Imatinib Mesylate - A lay language summary of important information about this drug that may include the following: | MedlinePlus Information on Imatinib Mesylate - A lay language summary of important information about this drug that may include the following: | ||
| + | <!--T:21--> | ||
*warnings about this drug, | *warnings about this drug, | ||
| + | <!--T:22--> | ||
* this drug is used for and how it is used, | * this drug is used for and how it is used, | ||
| + | <!--T:23--> | ||
*what you should tell your doctor before using this drug, | *what you should tell your doctor before using this drug, | ||
| + | <!--T:24--> | ||
*what you should know about this drug before using it, | *what you should know about this drug before using it, | ||
| + | <!--T:25--> | ||
*other drugs that may interact with this drug, and | *other drugs that may interact with this drug, and | ||
| + | <!--T:26--> | ||
*possible side effects. | *possible side effects. | ||
| + | <!--T:27--> | ||
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. | ||
| + | <!--T:28--> | ||
'''Research Results and Related Resources''' | '''Research Results and Related Resources''' | ||
| + | <!--T:29--> | ||
Targeted Cancer Therapies | Targeted Cancer Therapies | ||
| + | <!--T:30--> | ||
'''Clinical Trials Accepting Patients''' | '''Clinical Trials Accepting Patients''' | ||
| + | <!--T:31--> | ||
Find Clinical Trials for Imatinib Mesylate - Check for trials from NCI's list of cancer clinical trials now accepting patients. | Find Clinical Trials for Imatinib Mesylate - Check for trials from NCI's list of cancer clinical trials now accepting patients. | ||
| + | <!--T:32--> | ||
'''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | '''Important:''' The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug. | ||
</translate> | </translate> | ||
Latest revision as of 21:33, 29 October 2019
Imatinib Mesylate
This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Gleevec
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Imatinib mesylate is approved to treat:
- Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment). In children, it is used as the first treatment after the disease is diagnosed.
- Chronic eosinophilic leukemia or hypereosinophilic syndrome.
- Chronic myelogenous leukemia that is Philadelphia chromosome positive.
- Dermatofibrosarcoma protuberans.
- Gastrointestinal stromal tumor (GIST).
- Myelodysplastic/myeloproliferative neoplasms.
- Systemic mastocytosis.
Imatinib mesylate is also being studied in the treatment of other conditions and types of cancer.
More About Imatinib Mesylate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Imatinib Mesylate - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Targeted Cancer Therapies
Clinical Trials Accepting Patients
Find Clinical Trials for Imatinib Mesylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
